Rob Petrie
Chief Tech/Sci/R&D Officer bij PPD, INC.
Profiel
Rob Petrie is Chief Technology Officer & Senior Vice President bij PPD, Inc. De heer Petrie was voorheen werkzaam als Manager-Application Development bij Pharmaco. Hij behaalde zijn doctoraal aan de Universiteit van East Anglia en een MBA aan de Virginia Commonwealth University.
Actieve functies van Rob Petrie
| Bedrijven | Functie | Begin |
|---|---|---|
| PPD, INC. | Chief Tech/Sci/R&D Officer | 01-01-1998 |
Eerdere bekende functies van Rob Petrie
| Bedrijven | Functie | Einde |
|---|---|---|
Pharmaco
 Pharmaco Drugstore ChainsRetail Trade Pharmaco acquires, develops and markets niche pharmaceutical products. The company was founded by Rick J. Hawkins in 1983 and is headquartered in Atlanta, GA. | Corporate Officer/Principal | - |
Opleiding van Rob Petrie
| Virginia Commonwealth University | Masters Business Admin |
| University of East Anglia | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Pharmaco
Pharmaco Drugstore ChainsRetail Trade Pharmaco acquires, develops and markets niche pharmaceutical products. The company was founded by Rick J. Hawkins in 1983 and is headquartered in Atlanta, GA. | Retail Trade |
PPD, Inc.
 PPD, Inc. Miscellaneous Commercial ServicesCommercial Services PPD, Inc. engages in the provision of drug development services to the biopharmaceutical industry, focuses on helping customers bring their new medicines to patients around the world. It operates through the Clinical Development Services and Laboratory Services segments. The Clinical Development Services segment focuses in early development/Phase I, patient recruitment and enrollment, investigator site management, Phase II-IV clinical trial management, medical communications and various peri- and post-approval services. The Laboratory Services segment comprises of bioanalytical, vaccine sciences, GMP, central lab and biomarker testing. The company was founded by Fred Eshelma in 1985 and is headquartered in Wilmington, NC. | Commercial Services |
